The global botulism treatment, a critical yet highly specialized segment of the biopharmaceutical industry, is witnessing a stable expansion driven by the indispensable need for rapid-response therapeutics and increasing global food safety surveillance. The market, which primarily centers on the provision of life-saving antitoxins and advanced supportive care, was valued at USD 1.08 b... https://www.databridgemarketresearch.com/reports/global-botulism-treatment-market